627 related articles for article (PubMed ID: 14696453)
1. Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan.
Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kobashigawa K; Kinjo F; Saito A
Hepatogastroenterology; 2003; 50(54):2005-8. PubMed ID: 14696453
[TBL] [Abstract][Full Text] [Related]
2. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.
Caldwell SH; Oelsner DH; Iezzoni JC; Hespenheide EE; Battle EH; Driscoll CJ
Hepatology; 1999 Mar; 29(3):664-9. PubMed ID: 10051466
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.
Poonawala A; Nair SP; Thuluvath PJ
Hepatology; 2000 Oct; 32(4 Pt 1):689-92. PubMed ID: 11003611
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of obesity, diabetes mellitus and hyperlipidaemia in patients with cryptogenic liver cirrhosis.
Duseja A; Nanda M; Das A; Das R; Bhansali A; Chawla Y
Trop Gastroenterol; 2004; 25(1):15-7. PubMed ID: 15303464
[TBL] [Abstract][Full Text] [Related]
5. Cryptogenic cirrhosis and NAFLD: are they related?
Maheshwari A; Thuluvath PJ
Am J Gastroenterol; 2006 Mar; 101(3):664-8. PubMed ID: 16464222
[TBL] [Abstract][Full Text] [Related]
6. Chronic liver disease in diabetes mellitus.
Amarapurkar D; Das HS
Trop Gastroenterol; 2002; 23(1):3-5. PubMed ID: 12170918
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus.
Arao M; Murase K; Kusakabe A; Yoshioka K; Fukuzawa Y; Ishikawa T; Tagaya T; Yamanouchi K; Ichimiya H; Sameshima Y; Kakumu S
J Gastroenterol; 2003; 38(4):355-60. PubMed ID: 12743775
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
Papatheodoridis GV; Chrysanthos N; Savvas S; Sevastianos V; Kafiri G; Petraki K; Manesis EK
J Viral Hepat; 2006 May; 13(5):303-10. PubMed ID: 16637860
[TBL] [Abstract][Full Text] [Related]
9. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
Ong J; Younossi ZM; Reddy V; Price LL; Gramlich T; Mayes J; Boparai N
Liver Transpl; 2001 Sep; 7(9):797-801. PubMed ID: 11552214
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
[TBL] [Abstract][Full Text] [Related]
11. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
12. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis.
Ratziu V; Bonyhay L; Di Martino V; Charlotte F; Cavallaro L; Sayegh-Tainturier MH; Giral P; Grimaldi A; Opolon P; Poynard T
Hepatology; 2002 Jun; 35(6):1485-93. PubMed ID: 12029634
[TBL] [Abstract][Full Text] [Related]
13. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence and significance of type-2 diabetes mellitus in chronic liver disease, correlated with hepatitis C virus].
Brischetto R; Corno C; Amore MG; Leotta S; Pavone S; Bonsignore L; Calcagno MP; Calcara G
Ann Ital Med Int; 2003; 18(1):31-6. PubMed ID: 12739426
[TBL] [Abstract][Full Text] [Related]
15. [Liver cirrhosis in diabetes mellitus; a complication not always recognized].
Thewissen CM; Tiebosch AT; Kloppenburg WD; Haagsmna EB; Hoogenberg K
Ned Tijdschr Geneeskd; 2008 Nov; 152(44):2369-74. PubMed ID: 19055132
[TBL] [Abstract][Full Text] [Related]
16. Obesity and diabetes as a risk factor for hepatocellular carcinoma.
Regimbeau JM; Colombat M; Mognol P; Durand F; Abdalla E; Degott C; Degos F; Farges O; Belghiti J
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S69-73. PubMed ID: 14762843
[TBL] [Abstract][Full Text] [Related]
17. Obesity, fatty liver and liver cancer.
Qian Y; Fan JG
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):173-7. PubMed ID: 15908310
[TBL] [Abstract][Full Text] [Related]
18. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
[TBL] [Abstract][Full Text] [Related]
19. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.
Trombetta M; Spiazzi G; Zoppini G; Muggeo M
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():24-7. PubMed ID: 16225467
[TBL] [Abstract][Full Text] [Related]
20. [The influence and prevalence of nonalcoholic steatohepatitis in chronic hepatitis B].
Pîrvulescu I; Suciu S; Andrei M; Lupu A; Diculescu M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):91-6. PubMed ID: 21688564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
